RR
Richard Ruedy
EVPClin&Reg.Affairs&QA

Richard Ruedy insider trades: Silk Road Medical (SILK) stock sales

EVPClin&Reg.Affairs&QA, Silk Road Medical Last trade Mar 5, 2024 17 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2019
1
Company
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Richard reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 5, 2024SILK↓ Sell$65K
Feb 29, 2024SILK↓ Sell$67K
Mar 6, 2023SILK↓ Sell$113K
Aug 27, 2021SILK↓ Sell$847K
Nov 17, 2020SILK↓ Sell$851K
Dec 18, 2019SILK↓ Sell$1.2M
Dec 18, 2019SILK↓ Sell$716K
Nov 25, 2019SILK↓ Sell$367K
Nov 22, 2019SILK↓ Sell$1.2M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Richard Ruedy's insider trades

Richard Ruedy is EVPClin&Reg.Affairs&QA at Silk Road Medical (SILK). Since Nov 22, 2019, Richard has reported no open-market purchases and 9 sales worth $5.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (8 filings), option exercises (7 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SILK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.